Target
Sepiapterin reductase
Ligand
BDBM659995
Substrate
n/a
Meas. Tech.
Measurement of Human SPR Inhibitory Activity Assay
IC50
0.660±n/a nM
Citation
 KAMAURA, MINABA, YSHINTANI, YKUWANO, YNAKAO, MNAGAI, HKUROSE, NTAKAYA, KNAKAJIMA, M CONDENSED HETEROCYCLIC COMPOUND US Patent  US20240092784 Publication Date 3/21/2024
Target
Name:
Sepiapterin reductase
Synonyms:
SPR | SPRE_HUMAN | Sepiapterin reductase (SPR)
Type:
Enzyme
Mol. Mass.:
28050.66
Organism:
Homo sapiens (Human)
Description:
P35270
Residue:
261
Sequence:
MEGGLGRAVCLLTGASRGFGRTLAPLLASLLSPGSVLVLSARNDEALRQLEAELGAERSGLRVVRVPADLGAEAGLQQLLGALRELPRPKGLQRLLLINNAGSLGDVSKGFVDLSDSTQVNNYWALNLTSMLCLTSSVLKAFPDSPGLNRTVVNISSLCALQPFKGWALYCAGKAARDMLFQVLALEEPNVRVLNYAPGPLDTDMQQLARETSVDPDMRKGLQELKAKGKLVDCKVSAQKLLSLLEKDEFKSGAHVDFYDK
  
Inhibitor
Name:
BDBM659995
Synonyms:
N-Cyclopropyl-3-((E)-3-((3S,5S)-3,5-dimethylmorpholino)-3-oxoprop-1-en-1-yl)-7-hydroxy-4-isobutyl-2-(methylamino)-5-oxo-4,5-dihydropyrazolo[1,5-a]pyrimidine-6-carboxamide | US20240092784, Example 432
Type:
Small organic molecule
Emp. Form.:
C24H34N6O5
Mol. Mass.:
486.564
SMILES:
CNc1nn2c(O)c(C(=O)NC3CC3)c(=O)n(CC(C)C)c2c1\C=C\C(=O)N1[C@@H](C)COC[C@@H]1C
Structure:
Search PDB for entries with ligand similarity: